Trial of iLet bionic pancreas (dual insulin and glucagon pump)

Status
Not open for further replies.

Amity Island

Well-Known Member
Relationship to Diabetes
Type 1
Children’s National Hospital (U.S) has been selected to participate in a multi-center clinical trial to test the efficacy of the iLet bionic pancreas — a device that automatically regulates blood sugar levels in patients with Type 1 diabetes.

“This trial is important as it represents the first dual chamber pump to manage glucose levels,” says Meighan. “It could potentially change the way we treat diabetes entirely. It represents a hope to our patients and families that one day this disease will have far less of a daily burden than it currently does.”


 
Status
Not open for further replies.
Back
Top